UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 16 filers reported holding UNICYCIVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,660 | +34.4% | 31,000 | +100.0% | 0.01% | -30.8% |
| Q2 2023 | $19,840 | -39.0% | 15,500 | 0.0% | 0.01% | -43.5% |
| Q1 2023 | $32,550 | +288.9% | 15,500 | 0.0% | 0.02% | +228.6% |
| Q4 2022 | $8,370 | -16.3% | 15,500 | 0.0% | 0.01% | -12.5% |
| Q3 2022 | $10,000 | -23.1% | 15,500 | 0.0% | 0.01% | -20.0% |
| Q2 2022 | $13,000 | -23.5% | 15,500 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $17,000 | -46.9% | 15,500 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $32,000 | -27.3% | 15,500 | 0.0% | 0.02% | -35.7% |
| Q3 2021 | $44,000 | – | 15,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 647,416 | $1,359,574 | 0.10% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 15,500 | $32,550 | 0.02% |
| BALYASNY ASSET MANAGEMENT L.P. | 717,349 | $1,506,433 | 0.00% |
| Oxbow Advisors, LLC | 11,861 | $24,908 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 95,898 | $201,385 | 0.00% |
| STATE STREET CORP | 35,036 | $73,576 | 0.00% |
| TWO SIGMA ADVISERS, LP | 14,600 | $30,660 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 18,800 | $39,480 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,419 | $7 | 0.00% |